T 2157/21 of 20.06.2024
- European Case Law Identifier
- ECLI:EP:BA:2024:T215721.20240620
- Date of decision
- 20 June 2024
- Case number
- T 2157/21
- Petition for review of
- -
- Application number
- 15843405.0
- IPC class
- C07C 233/47C07D 257/04A61K 31/41
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Crystalline forms of trisodium supramolecular complex comprising valsartan and AHU-377 and methods thereof
- Applicant name
- Crystal Pharmatech Co., Ltd.
Suzhou Pengxu Pharmatech Co., Ltd. - Opponent name
- D Young & Co LLP
- Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 100(c)European Patent Convention Art 123(2)European Patent Convention Art 56
- Keywords
- Amendments - added subject-matter (yes)
Inventive step - auxiliary requests 12, 12A, 13, 16, 16A, 17 (no) - Catchword
- -
- Cited cases
- -
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The patent is revoked.